| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 10/11/2007 | US20070238886 Recovery of Phytonutrients from Oils |
| 10/11/2007 | US20070238759 Novel Polymorph V of Torasemide |
| 10/11/2007 | US20070238747 Rifamycin analogs and uses thereof |
| 10/11/2007 | US20070238740 Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use |
| 10/11/2007 | US20070238736 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-[4-(Benzo [1,3]dioxole-5-carbonyl)-piperazin-1-yl]-1-(4-fluoro-benzyl)-2-oxo-1,2-dihydro-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder |
| 10/11/2007 | US20070238099 Antigen Receptor Variable Region Typing |
| 10/11/2007 | US20070237876 Oilseed plant that produces mature seeds producing arachidonic acid |
| 10/10/2007 | EP1842918A1 Receptor nucleic acids and polypeptides |
| 10/10/2007 | EP1646328B1 Treatment of dependence withdrawal |
| 10/10/2007 | EP1617850A4 Delivery vehicle for silver ions |
| 10/10/2007 | EP1546408A4 A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS |
| 10/10/2007 | EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/10/2007 | EP0915880B1 Azolo triazines and pyrimidines |
| 10/10/2007 | CN101052415A Methods and compositions for treating and preventing inflammatory conditions |
| 10/10/2007 | CN101052414A Immunogenic HBc chimer particles having enhanced stability |
| 10/10/2007 | CN101052401A Use of unsaturated quionoline or naphtalene derivatives as medicaments |
| 10/10/2007 | CN101052394A Treatment of acute myeloid leukemia with indolinone compounds |
| 10/10/2007 | CN101050445A Microbe for producing epothilone |
| 10/10/2007 | CN101049502A Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases |
| 10/10/2007 | CN100341573C Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 10/10/2007 | CN100341483C Improvements in or relating to delivery of oral drugs |
| 10/09/2007 | US7279579 Polymorphic forms of naltrexone |
| 10/09/2007 | US7279166 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 10/04/2007 | WO2007008080A3 Optical imaging contrast agents |
| 10/04/2007 | WO2005046575A3 Amino acid prodrugs |
| 10/04/2007 | WO2005030133A3 Treatment with agonists of toll-like receptors |
| 10/04/2007 | WO2005016239A3 Molecules enhancing dermal delivery of influenza vaccines |
| 10/04/2007 | WO2004071457A3 Improved heat shock protein-based vaccines and immunotherapies |
| 10/04/2007 | WO2004069193A3 Methods and compositions for inhibiting cholesterol uptake |
| 10/04/2007 | US20070232796 Medical Solution, a Method for Producing Said Medical Solution and Use Thereof |
| 10/04/2007 | US20070232684 Compounds for inhibition of HIV infection by blocking HIV entry |
| 10/04/2007 | US20070232597 Compounds, Compositions, and Methods |
| 10/04/2007 | US20070231809 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
| 10/04/2007 | US20070231382 Pharmaceutical composition |
| 10/03/2007 | EP1840134A2 GLP-1 derivatives |
| 10/03/2007 | EP1840117A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 10/03/2007 | EP1839648A2 An inhalation system |
| 10/03/2007 | EP1838734A2 Antibodies against antigen presenting cells and uses thereof |
| 10/03/2007 | EP1648384A4 Stable aluminum/zirconium antiperspirant solution |
| 10/03/2007 | EP1623034A4 Mechanisms of myoblast transfer in treating heart failure |
| 10/03/2007 | EP1558219B1 Pharmaceutical formulation of olanzapine |
| 10/03/2007 | EP1490361B1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 10/03/2007 | EP1294378B1 Thrombopoietin mimetics |
| 10/03/2007 | CN101048392A Novel use |
| 10/03/2007 | CN101045039A Dosage form for treatment of diabetes mellitus |
| 10/03/2007 | CN100340559C Nitrogen containing heterobicycles as factor XA inhibitors |
| 10/02/2007 | US7277749 Treatments for snoring using injectable neuromuscular stimulators |
| 10/02/2007 | US7276608 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 10/02/2007 | US7276599 Oligonucleotide synthesis with alternative solvents |
| 10/02/2007 | US7276588 Antibody of human mitochondrial voltage dependent anion channel |
| 10/02/2007 | US7276539 In which the phenyl group is p-substituted with a 2-(p-(methylsulfonyloxy)phenoxy)ethyl group; used for treating type 2 diabetes and dyslipidemia; may be combined with atorvastatin, rosuvastatin, or an IBAT inhibitor. |
| 10/02/2007 | US7276481 Method and composition for treatment of skeletal dysplasias |
| 10/02/2007 | US7276353 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule. |
| 10/02/2007 | US7276243 Nucleic acid having a sequence that is codon-optimized for high level expression in a yeast cell; proteins produced provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity |
| 10/02/2007 | CA2532332C Dietary supplement for promoting control of blood-sugar levels and associated pathology in type 2 diabetics |
| 10/02/2007 | CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase |
| 09/27/2007 | WO2005046583A3 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 09/27/2007 | US20070225373 Zn2Motif-Tethered Short-Chain Fatty Acids as a Novel Class of Histone Deacetylase |
| 09/27/2007 | US20070225307 C-met modulators and method of use |
| 09/27/2007 | US20070225251 Method for Treating or Inhibiting the Effects of Injuries or Diseases that Result in Neuronal Degeneration |
| 09/27/2007 | US20070225210 Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 09/27/2007 | US20070224287 Methods of Modulating Inflammatory Reactions by Modulating Xanthine Oxidoreductase Activity |
| 09/27/2007 | US20070224196 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 09/27/2007 | US20070224166 Uses of mammalian cytokine; related reagents |
| 09/26/2007 | EP1837031A1 Compositions and methods for treating diabetes |
| 09/26/2007 | EP1622577A4 Prevention of deficits in neurogenesis with anti-inflammatory agents |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1363650B1 Composition containing pimenta extract in aquatic animal treatment methods |
| 09/26/2007 | EP1339678B1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 09/26/2007 | EP1322673B1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 09/26/2007 | EP1041921B1 Preemptive prophylaxis of migraine device |
| 09/26/2007 | CN101040854A Method of treatment of diabetes with a combination of a thiazolidinedione and metformin |
| 09/26/2007 | CN100339371C Novel aryloxy-alkyl-dialkylamines compound |
| 09/26/2007 | CN100339130C 疫苗 Vaccine |
| 09/25/2007 | US7273858 Salts |
| 09/25/2007 | US7273753 Comprises separation via anti-CD2 antibodies/stimulation of interleukin production; vaccines; immunotherapy; anticancer agents |
| 09/25/2007 | US7273600 unit dose comprises a sufficient amount for in vivo diagnostic imaging of a 2'-deoxy-2'-[18F]- or a 3'-deoxy-3'-[18F]-labeled purine analog for being detected in vivo |
| 09/25/2007 | US7273445 Intraocular brachytherapy device and method |
| 09/25/2007 | CA2200967C Pharmaceutical compositions |
| 09/20/2007 | WO2005011590A3 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 09/20/2007 | WO2004082597A3 Homeopathic formulations useful for treating pain and/or inflammmation |
| 09/20/2007 | US20070219607 Apparatus and method for the treatment of infectious disease in keratinized tissue |
| 09/20/2007 | US20070219200 Prodrugs of heteroaryl compounds |
| 09/20/2007 | US20070218551 Novel Sirna-Based Approach to Target the Hif-Alpha Factor for Gene Therapy |
| 09/20/2007 | US20070218056 Methods for identification, diagnosis, and treatment of breast cancer |
| 09/19/2007 | EP1834976A1 Anion-binding polymers and uses thereof |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1833491A1 Topical compositions comprising one or more of 44-thiouridine, isomaltitol and uridine |
| 09/19/2007 | EP1684702B1 Use of 2-thia-dibenzo[e,h]azulenes for the treatment and prevention of central nervous system diseases and disorders |
| 09/19/2007 | EP1677733A4 Gene expression profiles and methods of use |
| 09/19/2007 | EP1648439A4 Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
| 09/19/2007 | EP1585734A4 Anti-inflammatory medicaments |
| 09/19/2007 | EP1157094B1 Method for the purification, recovery, and sporulation of cysts and oocysts |
| 09/19/2007 | CN101039957A Synthetic chemokine receptor ligands and methods of use thereof |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271146 Methods for treatment of Helicobacter pylori-associated disorders |
| 09/18/2007 | US7270975 Methods for regulating bud-hypha transitions and cAMP levels in Candida albicans |
| 09/18/2007 | US7270850 Mesoporous permeation layers for use on active electronic matrix devices |
| 09/18/2007 | US7270815 2-O sulfatase compositions and related methods |
| 09/18/2007 | US7270440 Make-up applicator with LED light source |